NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO
Rhea-AI Summary
Nutex Health (NASDAQ: NUTX) will attend and present at the 2026 J.P. Morgan Healthcare Conference in San Francisco on January 12–15, 2026. Company executives attending include CEO Tom Vo, M.D., MBA, CFO Jon Bates, and President Warren Hosseinion. Nutex Health's presentation is scheduled for Wednesday, January 14, 2026 at 4:30 PM PST at The Westin St. Francis.
The company is a physician-led integrated healthcare delivery system operating 26 micro hospitals and hospital outpatient departments across 12 states, with primary care-centric risk-bearing physician networks.
Positive
- None.
Negative
- None.
News Market Reaction – NUTX
In the Jan 5 session, NUTX gained 13.13%, reflecting a significant positive market reaction. Argus tracked a peak move of +10.6% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 22 | Facility opening | Positive | +4.4% | Opened Archview ER & Hospital as 26th facility and first in Missouri. |
| Dec 04 | Share repurchase | Positive | +19.0% | Extended $25.0M common stock repurchase program through March 31, 2026. |
| Nov 26 | Short report response | Negative | -5.4% | Company responded publicly to a short seller report on its business. |
| Nov 24 | Facility reopening | Positive | +0.2% | Reopened Red River ER & Hospital in Sherman, Texas with upgraded services. |
| Nov 19 | Earnings update | Positive | +13.1% | Reported strong Q3 and nine‑month 2025 results with higher revenue and income. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news-driven moves have generally been positive for NUTX, with hospital expansion and strong earnings updates aligning with favorable price reactions.
This announcement adds to a series of operating and capital markets developments for Nutex Health. In late 2025, the company opened its 26th hospital in St. Louis and reopened the Red River ER & Hospital in Texas, underscoring its micro hospital growth strategy. A $25.0M share repurchase extension through March 31, 2026 and strong nine‑month 2025 financial results with revenue of $723.6M and net income of $59.0M were followed by generally positive price reactions. The new J.P. Morgan conference appearance highlights ongoing investor outreach alongside this expansion and earnings momentum.
Key Terms
micro hospitals medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Presentation Details:
Speaker: Tom Vo, M.D., MBA, Chairman of the Board & CEO
Date: Wednesday, January 14, 2026
Time: 4:30 PM PST
Location: The Westin St. Francis
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 26 facilities in 12 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words or phrases "will," "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2025, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-to-attend-and-present-at-the-2026-jp-morgan-healthcare-conference-in-january-in-san-francisco-302651487.html
SOURCE Nutex Health, Inc.